• 1. Department of Cardiac Surgery, Xinjiang Cardiovascular and Cerebrovascular Disease Hospital, Urumqi, 830011, P. R. China;
  • 2. Department of Ultrasound, Xinjiang Cardiovascular and Cerebrovascular Disease Hospital, Urumqi, 830011, P. R. China;
CHENG Duan, Email: chengduan@126.com
Export PDF Favorites Scan Get Citation

Objective To compare the surgical results of ultrasound-guided percutaneous antegrade or retrograde therapy in the treatment of patent ductus arteriosus.Methods The clinical data of 166 patients (44 males and 122 females) who underwent transthoracic echocardiography guided closure of patent ductus arteriosus in Xinjiang Cardiovascular and Cerebrovascular Disease Hospital from February 2016 to August 2020 were retrospectively analyzed, and the patients were divided into two groups: an antegrade group (n=60) and a retrograde group (n=106). The operation time, success rate, bed rest time, postoperative complications and surgical safety were compared between the two groups.Results The immediate success rate of the two groups was 100.0%. Compared with the retrograde group, the antegrade group had shorter time of bed rest and hospital stay, but longer operation time. In the retrograde group, there were 2 patients of complications, including occlusive device falling off to pulmonary artery 12 hours after the operation in 1 patient, and false arterial tumor in 1 patient. Both groups were followed up for 3-18 months, and there was no death in the whole group.Conclusion It is safe and effective to block patent ductus arteriosus under the guidance of transthoracic echocardiography. Although the operation process of anterior occlusion of patent ductus arteriosus is slightly complex and the operation time is long, the indication is wide, and the bed rest time is short. Therefore it can be used as the first choice for patent ductus arteriosus occlusion.

Citation: SUN Bao, CHENG Duan, LI Bo, HE Guibao, WANG Haifeng, Ahati  , Elias  , SHENG Xi, LI Jinpeng. Treatment of patent ductus arteriosus via ultrasound-guided percutaneous antegrade or retrograde access: A retrospective cohort study. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(8): 1020-1023. doi: 10.7507/1007-4848.202010020 Copy

  • Previous Article

    Application of orthotopic autologous renal transplantation combined with inferior vena cava resection and reconstruction in retroperitoneal tumor
  • Next Article

    Postoperative pulmonary complications following thoracic surgery during COVID-19 pandemic